NEW YORK, April 26 (GenomeWeb News) - Fisher Biosciences has acquired BioImage for an undisclosed amount in an effort to expand its high-content screening and analysis reagent play, the company said today.
BioImage plays in the high-content pathway-analysis market. Its Redistribution technology monitors protein translocation within a cell.
Fisher said BioImage, based in Copenhagen, Denmark, complements its Cellomics business, which sells automated imaging instruments, BioApplication image-analysis software, high content informatics software, and HitKit HCS reagent kits.
Fisher will continue BioImage's operations in Copenhagen.
Additional details were not disclosed.